📗 Cite This Artifact
CTNNBIP1 Gene — Catenin Beta Interacting Protein 1 (ICAT)
<div class="infobox infobox-gene">
<div class="infobox-header">CTNNBIP1 — Catenin Beta Interacting Protein 1</div>
| Attribute | Value |
|-----------|-------|
| Gene Symbol | CTNNBIP1 |
| Full Name | Catenin Beta Interacting Protein 1 |
| Synonyms | ICAT, Beta-catenin Inhibitor |
| Chromosomal Location | 1p36.22 |
| NCBI Gene ID | 56951 |
| Ensembl ID | ENSG00000162391 |
| UniProt ID | Q4G0C4 |
| Gene Type | Protein coding |
| OMIM | 607012 |
| Protein Length | 81 amino acids |
| Expression | Brain, especially during development |
</div>
CTNNBIP1 Gene — Catenin Beta Interacting Protein 1 (ICAT)
Overview
CTNNBIP1 encodes Catenin Beta Interacting Protein 1 (also known as ICAT — Inhibitor of Beta-Catenin and TCF-4), a small nuclear protein that functions as a negative regulator of Wnt/β-catenin signaling [@clevers2006]. First identified in 2001, ICAT plays critical roles in brain development, synaptic plasticity, and has been increasingly implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD) [@inestrosa2012].
The Wnt/β-catenin pathway is one of the most fundamental signaling cascades in biology, controlling embryonic development, tissue homeostasis, and adult brain function. CTNNBIP1 provides a crucial brake on this pathway by preventing excessive β-catenin-mediated transcription, thereby ensuring appropriate gene expression during development and in the mature nervous system.
Gene Structure and Evolution
Genomic Organization
...
<div class="infobox infobox-gene">
<div class="infobox-header">CTNNBIP1 — Catenin Beta Interacting Protein 1</div>
| Attribute | Value |
|-----------|-------|
| Gene Symbol | CTNNBIP1 |
| Full Name | Catenin Beta Interacting Protein 1 |
| Synonyms | ICAT, Beta-catenin Inhibitor |
| Chromosomal Location | 1p36.22 |
| NCBI Gene ID | 56951 |
| Ensembl ID | ENSG00000162391 |
| UniProt ID | Q4G0C4 |
| Gene Type | Protein coding |
| OMIM | 607012 |
| Protein Length | 81 amino acids |
| Expression | Brain, especially during development |
</div>
CTNNBIP1 Gene — Catenin Beta Interacting Protein 1 (ICAT)
Overview
CTNNBIP1 encodes Catenin Beta Interacting Protein 1 (also known as ICAT — Inhibitor of Beta-Catenin and TCF-4), a small nuclear protein that functions as a negative regulator of Wnt/β-catenin signaling [@clevers2006]. First identified in 2001, ICAT plays critical roles in brain development, synaptic plasticity, and has been increasingly implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD) [@inestrosa2012].
The Wnt/β-catenin pathway is one of the most fundamental signaling cascades in biology, controlling embryonic development, tissue homeostasis, and adult brain function. CTNNBIP1 provides a crucial brake on this pathway by preventing excessive β-catenin-mediated transcription, thereby ensuring appropriate gene expression during development and in the mature nervous system.
Gene Structure and Evolution
Genomic Organization
The CTNNBIP1 gene is located on chromosome 1p36.22, a region implicated in various developmental disorders and cancers. The gene spans approximately 12 kb and consists of:
- Exon 1: 5' UTR and start codon
- Exons 2-3: Coding sequence
- Exon 4: 3' UTR with regulatory elements
Protein Structure
CTNNBIP1 (ICAT) is a compact 81-amino acid protein with two functional domains:
The protein lacks known enzymatic activity and functions purely as an adaptor, simultaneously binding β-catenin and TCF to prevent their productive interaction. This bipartite binding is essential for its inhibitory function.
Evolution and Conservation
CTNNBIP1 is conserved across vertebrates but shows limited conservation with invertebrate orthologs:
- Homo sapiens: 81 amino acids
- Mus musculus: 79 amino acids (97% identity)
- Gallus gallus: 78 amino acids
- Danio rerio: 75 amino acids
- Drosophila melanogaster: No clear ortholog
The rapid evolution suggests relatively recent acquisition of regulatory functions in vertebrates.
Normal Physiological Function
Wnt/β-Catenin Pathway Overview
The canonical Wnt/β-catenin pathway controls gene expression through the following mechanism:
CTNNBIP1 as Negative Regulator
CTNNBIP1 interrupts this pathway at multiple points:
This dual-blocking mechanism makes ICAT one of the most potent endogenous inhibitors of β-catenin transcriptional activity.
Functions in Brain Development
During development, CTNNBIP1 is essential for:
The spatial and temporal expression of CTNNBIP1 during development ensures appropriate Wnt signaling levels in specific brain regions.
Functions in Adult Brain
In the mature nervous system, CTNNBIP1 continues to regulate:
Tissue-Specific Expression
CTNNBIP1 is predominantly expressed in:
- Brain: Highest expression in hippocampus, cortex, and cerebellum
- Testis: Lower but significant expression
- Embryonic tissues: During early development
In the brain, ICAT is enriched in:
- Pyramidal neurons of the hippocampus
- Cortical layer 2-3 neurons
- Cerebellar Purkinje cells
Role in Alzheimer's Disease
Wnt Signaling Dysfunction in AD
Multiple lines of evidence implicate Wnt signaling disruption in AD:
CTNNBIP1 in AD Pathogenesis
The role of CTNNBIP1 in AD is complex and context-dependent:
Mechanisms
CTNNBIP1 contributes to AD-related pathology through:
Therapeutic Implications
Modulating CTNNBIP1 or the broader Wnt pathway offers therapeutic opportunities:
Role in Parkinson's Disease
Wnt Signaling in PD
The Wnt pathway is increasingly recognized as relevant to PD:
CTNNBIP1 in PD
Evidence for CTNNBIP1 involvement in PD:
Mechanisms
CTNNBIP1 affects PD through:
Therapeutic Potential
Wnt pathway modulation may benefit PD:
- Neuroprotective effects in dopaminergic neurons
- Enhanced protein clearance
- Reduced neuroinflammation
Role in Neurodevelopment
Neural Stem Cell Regulation
CTNNBIP1 critically regulates neural stem cells:
Synaptogenesis
During synapse formation:
- Postsynaptic density organization
- Dendritic spine morphology
- Synaptic protein recruitment
- Activity-dependent remodeling
Axon Guidance
Wnt signaling guides axon extension:
- Growth cone turning responses
- Midline crossing
- Topographic mapping
- Circuit refinement
Neurodevelopmental Disorders
Dysregulated CTNNBIP1 may contribute to:
- Intellectual disability
- Autism spectrum disorders
- Schizophrenia
- Lissencephaly (when mutated)
Molecular Mechanisms
Interactions with Beta-Catenin
CTNNBIP1 binds β-catenin through:
- Central repeat domain (R1-R3)
- Hydrophobic interactions
- Phosphorylation-regulated binding
This interaction is modulated by:
- β-catenin phosphorylation state
- ICAT post-translational modifications
- Cellular context
Interactions with TCF/LEF
The TCF interaction involves:
- HMG domain binding
- DNA-contacting regions
- Competition with β-catenin
TCF family members (TCF1, LEF1, TCF3, TCF4) are differentially affected by ICAT.
Target Genes
Wnt/β-catenin targets relevant to neurodegeneration:
- Neurotrophic factors: BDNF, NGF
- Anti-apoptotic proteins: Bcl-2, survivin
- Metabolic enzymes: Hexokinases
- Synaptic proteins: Synapsins, PSD-95
Therapeutic Targeting
Wnt Pathway Modulators
Several approaches are in development:
CTNNBIP1-Directed Approaches
Direct targeting of ICAT:
- Modulation: Compounds that normalize ICAT expression
- Protein-protein interaction disrupters: When ICAT is overexpressed
- Gene therapy: Viral vectors expressing ICAT
Challenges
Key challenges include:
- Selectivity: Avoiding off-target effects in other pathways
- Brain penetration: Therapeutic delivery to CNS
- Timing: Optimal intervention window
- Cell type specificity: Targeting affected neurons
Research Directions
Biomarker Development
- ICAT levels in cerebrospinal fluid
- Genetic variants and disease risk
- Expression as disease progression marker
Drug Development
- High-throughput screening for Wnt modulators
- Structure-based design of ICAT-targeted compounds
- Combination therapy development
Genetic Studies
- GWAS for CTNNBIP1 variants in neurodegeneration
- Functional validation of risk variants
- Gene-environment interactions
Model Systems
- In vitro neuronal cultures
- Animal models with genetic modifications
- Human iPSC-derived neurons
Key Publications
See Also
- [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
- [Beta-Catenin](/proteins/beta-catenin)
- [TCF/LEF Transcription Factors](/mechanisms/tcf-lef-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neurogenesis](/mechanisms/neurogenesis)
External Links
- NCBI Gene: [CTNNBIP1](https://www.ncbi.nlm.nih.gov/gene/56951)
- Ensembl: [ENSG00000162391](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000162391)
- UniProt: [Q4G0C4](https://www.uniprot.org/uniprot/Q4G0C4)
- GeneCards: [CTNNBIP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CTNNBIP1)
- OMIM: [607012](https://www.omim.org/entry/607012)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-ctnnbip1 |
| kg_node_id | CTNNBIP1 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-a6be47176753 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ctnnbip1'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-ctnnbip1?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[CTNNBIP1 Gene — Catenin Beta Interacting Protein 1 (ICAT)](http://scidex.ai/artifact/wiki-genes-ctnnbip1)
http://scidex.ai/artifact/wiki-genes-ctnnbip1